-
1
-
-
0028930910
-
Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease
-
Adamus WS, Leonhard JP, Tröger W (1995) Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease. Life Sci 56:883-890
-
(1995)
Life Sci
, vol.56
, pp. 883-890
-
-
Adamus, W.S.1
Leonhard, J.P.2
Tröger, W.3
-
2
-
-
0014639050
-
Modification of arterial blood pressure in rats following microinjection of drugs in the posterior hypothalamus
-
Brezenoff HE, Jenden D (1969) Modification of arterial blood pressure in rats following microinjection of drugs in the posterior hypothalamus. Int J Neuropharmacol 8:593-600
-
(1969)
Int J Neuropharmacol
, vol.8
, pp. 593-600
-
-
Brezenoff, H.E.1
Jenden, D.2
-
3
-
-
0029948512
-
The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension
-
Buccafusco JJ (1996) The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol Rev 48:179-211
-
(1996)
Pharmacol Rev
, vol.48
, pp. 179-211
-
-
Buccafusco, J.J.1
-
4
-
-
0027318608
-
Mechanism of the hypertensive response to central injection of nicotine in conscious rats
-
Buccafusco JJ, Yang X-H (1993) Mechanism of the hypertensive response to central injection of nicotine in conscious rats. Brain Res Bull 32:35-41
-
(1993)
Brain Res Bull
, vol.32
, pp. 35-41
-
-
Buccafusco, J.J.1
Yang, X.-H.2
-
5
-
-
0027396773
-
WAL 2014: A muscarinic agonist with preferential neuron-stimulating properties
-
Ensinger HA, Doods HN, Immel-Sehr AR, Kuhn FJ, Lambrecht G, Mendla K, Müller RE, Mutschler E, Sagrada A, Walther G, Hammer R (1993) WAL 2014: A muscarinic agonist with preferential neuron-stimulating properties. Life Sci 52:473-480
-
(1993)
Life Sci
, vol.52
, pp. 473-480
-
-
Ensinger, H.A.1
Doods, H.N.2
Immel-Sehr, A.R.3
Kuhn, F.J.4
Lambrecht, G.5
Mendla, K.6
Müller, R.E.7
Mutschler, E.8
Sagrada, A.9
Walther, G.10
Hammer, R.11
-
6
-
-
0030916650
-
WAL 2014 FU (Talsaclidine): A preferentially neuron activating muscarinic agonist for the treatment of Alz-heimer's disease
-
Ensinger HA, Bechtel WD, Birke FW, Mendia KD, Mierau J, Speck G, Tröger W (1997) WAL 2014 FU (Talsaclidine): A preferentially neuron activating muscarinic agonist for the treatment of Alz-heimer's disease. Drug Dev Res 40:144-157
-
(1997)
Drug Dev Res
, vol.40
, pp. 144-157
-
-
Ensinger, H.A.1
Bechtel, W.D.2
Birke, F.W.3
Mendia, K.D.4
Mierau, J.5
Speck, G.6
Tröger, W.7
-
7
-
-
7144236303
-
Über den Einfluß von Eserin, Tetraäthylpyrophosphat (TEPP) und Neostigmin auf den Blutdruck und die pressorischen Carotissinusreflexe der Ratte
-
Hornykiewicz O, Kobinger W (1956) Über den Einfluß von Eserin, Tetraäthylpyrophosphat (TEPP) und Neostigmin auf den Blutdruck und die pressorischen Carotissinusreflexe der Ratte. Nau-nyn-Schmiedebergs Arch exp Path u Pharmak 228:493
-
(1956)
Nau-nyn-Schmiedebergs Arch Exp Path U Pharmak
, vol.228
, pp. 493
-
-
Hornykiewicz, O.1
Kobinger, W.2
-
8
-
-
0014179509
-
Über den Wirkmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur
-
Kobinger W (1967) Über den Wirkmechanismus einer neuen antihypertensiven Substanz mit Imidazolinstruktur. Naunyn-Schmiede-bergs Arch Pharmak 258:48-58
-
(1967)
Naunyn-Schmiede-bergs Arch Pharmak
, vol.258
, pp. 48-58
-
-
Kobinger, W.1
-
9
-
-
0014180678
-
Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichorphenylamino)-2-imidazoline-HC1
-
Kobinger W, Walland A (1967) Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichorphenylamino)-2-imidazoline-HC1. Eur J Pharmacol 2:155-162
-
(1967)
Eur J Pharmacol
, vol.2
, pp. 155-162
-
-
Kobinger, W.1
Walland, A.2
-
10
-
-
0025959015
-
Treatment of Alzheimer's disease with cholinergic drugs
-
Kumar V, Calache M (1991) Treatment of Alzheimer's disease with cholinergic drugs. Int J Clin Pharmacol Ther Toxicol 29:23-37
-
(1991)
Int J Clin Pharmacol Ther Toxicol
, vol.29
, pp. 23-37
-
-
Kumar, V.1
Calache, M.2
-
11
-
-
0029031111
-
Muscarinic receptor subtypes: Pharmacological, molecular biological and therapeutic aspects
-
Mutschler E, Moser U, Wess J, Lambrecht G (1995) Muscarinic receptor subtypes: Pharmacological, molecular biological and therapeutic aspects. Pharm Acta Helv 69:243-258
-
(1995)
Pharm Acta Helv
, vol.69
, pp. 243-258
-
-
Mutschler, E.1
Moser, U.2
Wess, J.3
Lambrecht, G.4
-
12
-
-
0025012942
-
Anatomical substates of cholinergic-autonomic regulation in the rat
-
Ruggiero DA, Giuliano R, Anwar N, Stornetta R, Reis DJ (1990) Anatomical substates of cholinergic-autonomic regulation in the rat. J Comp Neurol 292:1-53
-
(1990)
J Comp Neurol
, vol.292
, pp. 1-53
-
-
Ruggiero, D.A.1
Giuliano, R.2
Anwar, N.3
Stornetta, R.4
Reis, D.J.5
-
13
-
-
34250395736
-
cAMP as a second messenger in central blood pressure control
-
Walland A (1975) cAMP as a second messenger in central blood pressure control. Naunyn-Schmiedeberg's Arch Pharmacol 290: 419-423
-
(1975)
Naunyn-Schmiedeberg's Arch Pharmacol
, vol.290
, pp. 419-423
-
-
Walland, A.1
-
14
-
-
0030765986
-
Muscarinic contraction in isolated guinea-pig trachea and antagonism by noradrenaline
-
Walland A, Hammer R (1997) Muscarinic contraction in isolated guinea-pig trachea and antagonism by noradrenaline. Eur Respir J 10:1814-1819
-
(1997)
Eur Respir J
, vol.10
, pp. 1814-1819
-
-
Walland, A.1
Hammer, R.2
-
15
-
-
0343653019
-
The muscarinic agonist WAL 2014 FU antagonizes its bronchospastic potential in guinea pigs by activation of the sympathetic nervous system
-
Walland A, Palluk R (1994) The muscarinic agonist WAL 2014 FU antagonizes its bronchospastic potential in guinea pigs by activation of the sympathetic nervous system. Naunyn-Schmiedeberg's Arch Pharmacol 347:R115
-
(1994)
Naunyn-Schmiedeberg's Arch Pharmacol
, vol.347
-
-
Walland, A.1
Palluk, R.2
-
16
-
-
7144241051
-
Central activation of the sympathetic-nervous system by the muscarinic agonist talsaclidine in anaesthetized guinea pigs
-
Walland A, Pieper M (1997) Central activation of the sympathetic-nervous system by the muscarinic agonist talsaclidine in anaesthetized guinea pigs. Naunyn-Schmiedeberg's Arch Pharmacol 356:R14
-
(1997)
Naunyn-Schmiedeberg's Arch Pharmacol
, vol.356
-
-
Walland, A.1
Pieper, M.2
-
18
-
-
0030805077
-
Compensation of muscarinic bronchial effects of talsaclidine by concomitant sympathetic activation in guinea pigs
-
Walland A, Palluk R, Burkard St, Hammer R (1997b) Compensation of muscarinic bronchial effects of talsaclidine by concomitant sympathetic activation in guinea pigs. Eur J Pharmacol 330: 213-219
-
(1997)
Eur J Pharmacol
, vol.330
, pp. 213-219
-
-
Walland, A.1
Palluk, R.2
Burkard, St.3
Hammer, R.4
|